[Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) infections in Latin America]

Carlos Alvarez1, Jaime Labarca, Mauro Salles

  • 1División de Enfermedades Infecciosas, Departamento de Medicina Interna, Hospital Universitario San Ignacio y Pontificia Universidad Javeriana, Bogotá, Colombia. alvarezc@javeriana.edu.co

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) remains a global challenge due to inconsistent control measures. This review examines MRSA control policies and evidence in Latin America, offering recommendations for hospitals and communities.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Context:

  • Methicillin-resistant Staphylococcus aureus (MRSA) emerged in the 1970s, leading to widespread hospital transmission and a global pandemic.
  • Despite numerous prevention efforts, large-scale implementation of control measures has been inconsistent, contributing to ongoing transmission.
  • Current approaches to MRSA prevention and control remain debated, with frequent non-adherence to established protocols.

Purpose:

  • To review the current landscape of MRSA control policies in Latin America.
  • To evaluate the evidence supporting various MRSA control measures in both hospital and community settings.
  • To identify risk factors for MRSA infection and transmission, and assess the impact of antibiotic usage.

Summary:

  • This review synthesizes existing policies for MRSA control in Latin America, critically examining the evidence for implemented and proposed interventions.
  • It explores risk factors associated with MRSA infection and transmission among hospital patients and within diverse community populations.
  • The influence of antibiotic use on MRSA spread in healthcare and community environments is analyzed.

Impact:

  • Provides a comprehensive overview of the MRSA situation in Latin America, highlighting policy gaps and evidence limitations.
  • Offers evidence-based recommendations tailored for the Latin American context to improve MRSA prevention and control in hospitals and communities.
  • Aims to guide public health strategies and clinical practices to mitigate the impact of MRSA in the region.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...